Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

December 8, 2003

Ver artículo completo

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

RNRichard W. NestoGeneral / Preventive / Lipids DBDavid S.H. BellYahoo (United Kingdom)

Robert O. BonowStructural Heart Disease

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

HomeCirculationVol. 108, No. 23Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure | Synapse

Cite This Study

Nesto et al. (Mon,) studied this question.

synapsesocial.com/papers/69fbd7786c3a0c248625dca9 https://doi.org/https://doi.org/10.1161/01.cir.0000103683.99399.7e

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Oral Insulin Sensitizer, Thiazolidinedione, Increases Plasma Vascular Endothelial Growth Factor in Type 2 Diabetic Patients2001 · 58 citations
2Congestive Heart Failure in Type 2 Diabetes2001 · 603 citations
3Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats1997 · 106 citations
4Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis.2000 · 70 citations
5Heart Disease: A Textbook of Cardiovascular Medicine.1984 · 4,136 citations